Development Level

Tbio 4 | 10,625

Disease

Arsenic Poisoning 3 | 59
Cancer 3 | 2,346
glioblastoma 3 | 5,572
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
Cockayne syndrome 2 | 54
Fanconi's anemia 2 | 50
Neoplasm Metastasis 2 | 138
Neoplasms, Germ Cell and Embryonal 2 | 13
Peripheral Neuropathy 2 | 303
Photosensitive trichothiodystrophy 2 | 24
Testicular Neoplasms 2 | 5
Xeroderma pigmentosum 2 | 41
astrocytoma 2 | 1,493
diabetes mellitus 2 | 1,663
gastric cancer 2 | 430
hepatocellular carcinoma 2 | 532
nasopharyngeal carcinoma 2 | 1,056
non primary Sjogren syndrome sicca 2 | 840
osteosarcoma 2 | 7,933
ovarian cancer 2 | 8,484
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
psoriasis 2 | 6,685
Adenocarcinoma of lung (disorder) 1 | 48
Aplastic anemia 1 | 18
Arthritis 1 | 248
Asthma 1 | 349
Atherosclerosis 1 | 275
Bladder Neoplasm 1 | 109
Brain Ischemia 1 | 87
Breast cancer 1 | 3,094
CAMFAK syndrome 1 | 4
CEREBROOCULOFACIOSKELETAL SYNDROME 4 1 | 1
Cataract 1 | 104
Cerebrooculofacioskeletal Syndrome 1 1 | 4
Chromosome Aberrations 1 | 15
Cockayne Syndrome, Type I 1 | 3
Cockayne Syndrome, Type II 1 | 3
Dermatologic disorders 1 | 65
Eye disease 1 | 55
FANCONI ANEMIA, COMPLEMENTATION GROUP Q 1 | 1
Fanconi Anemia 1 | 19
Glomerulonephritis 1 | 36
Human immunodeficiency virus infectious disease 1 | 92
Hypersensitivity 1 | 63
Inflammation 1 | 109
Inflammatory bowel disease 1 | 142
Influenza 1 | 142
Liver disease 1 | 219
Lung Injury 1 | 20
Lung disease 1 | 132
Malaria 1 | 140
Melanoma 1 | 261
Micronuclei, Chromosome-Defective 1 | 19
Multiple Sclerosis 1 | 498
Myocardial Ischemia 1 | 169
Neutropenia 1 | 78
Pena Shokeir syndrome Type 2 1 | 4
Pneumonia 1 | 133
Progeria 1 | 22
Pulmonary Fibrosis 1 | 66
Stomach Neoplasms 1 | 282
Uterine Cervical Neoplasm 1 | 21
Vascular disease 1 | 281
XFE Progeroid Syndrome 1 | 1
Xeroderma pigmentosum, group F 1 | 1
aldosterone-producing adenoma 1 | 664
cutaneous lupus erythematosus 1 | 1,056
dermatomyositis 1 | 933
esophageal adenocarcinoma 1 | 737
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
interstitial cystitis 1 | 2,299
invasive ductal carcinoma 1 | 2,950
lung adenocarcinoma 1 | 2,713
lung cancer 1 | 4,466
lung carcinoma 1 | 2,844
medulloblastoma 1 | 1,524
medulloblastoma, large-cell 1 | 6,234
non-small cell lung cancer 1 | 2,798
non-small cell lung carcinoma 1 | 413
pancreatic cancer 1 | 2,300
pancreatic carcinoma 1 | 567
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
posterior fossa group A ependymoma 1 | 1,511
posterior fossa group B ependymoma 1 | 1,530
sonic hedgehog group medulloblastoma 1 | 1,482
tuberculosis 1 | 1,557
type I diabetes mellitus 1 | 22
ulcerative colitis 1 | 2,087

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 3 | 11,971
Enzyme 1 | 4,146

Grant Application

5R01ES016114-03 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
C-C motif chemokine 4 CCL4 Tbio Non-IDG -3.01434 903.5 334
CCR4-NOT transcription complex subunit 2 CNOT2 Tbio Non-IDG -2.81054 600.8 267
DNA repair endonuclease XPF ERCC4 Tbio Enzyme -2.40552 252.5 195
DNA excision repair protein ERCC-1 ERCC1 Tbio Non-IDG -2.94626 969.9 606